Huatai International
Hong Kong SARhtsc.com.hk
Overview
Huatai International Financial Holdings Company Limited (“Huatai International”) is a wholly-owned subsidiary of Huatai Securities Co., Limited . Huatai International operates its Hong Kong business via its wholly-owned subsidiary Huatai Financial Holdings (Hong Kong) Limited (“Huatai Financial”), which holds the SFC license to carry out type 1, 2, 3, 4, 6, 7, and 9 regulated activities . Huatai International carries US investment banking business via Huatai Securities (USA) . Huatai International is the Huatai Group's international arm, playing a crucial role in the group's internationalization strategy .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CAOCAO INC | Jun 2025 | IPO | Lead |
| Jiaxing Taimei Medical Technology | Oct 2024 | IPO | Co-investor |
| Lepu Biopharma | Feb 2022 | IPO | Co-investor |
| Remegen | Nov 2020 | IPO | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.